Daniel D. Burgess, COO/CFO at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), sold 2,250 shares at $5.50 ($12K) on 2007-02-14, disclosed to the SEC on 2007-02-15.
Scheduled sale ($12k) by COO/CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.49 | 195 | $1K | 8.6% |
| 2 | $5.50 | 1,655 | $9K | 73.5% |
| 3 | $5.51 | 400 | $2K | 17.8% |
| Total | $5.50 avg | 2,250 | $12K | 100% |
| Filing → |
| NBRV | BUY | 2018-08-02 | $99K | — | Filing → |
| CDTX | BUY | 2015-04-21 | $48K | — | Filing → |
| SNTS | SELL | 2013-06-04 | $171K | — | Filing → |